Table 1 Bacterial strains used in this study
From: In vitro synergy between sodium deoxycholate and furazolidone against enterobacteria
Name | Genotype or description | Source |
|---|---|---|
Escherichia coli O157 isolate ERL034336 | Human isolate | Dr. Ann Midwinter, School of Veterinary Sciences, Massey University, Palmerston North, New Zealand |
Escherichia coli UPEC P50 isolate | Isolate from a canine urinary tract infection | [41] |
Salmonella enterica LT2 | Type strain, S. enterica subsp. enterica, serovar Typhimurium | ATCC® 43971™ |
Citrobacter gillenii PMR001 | Isolate from a municipal sewage processing (water purification) plant, Palmerston North, New Zealand (classified by complete 16S rRNA sequencing, 99% identity over 1405 nt to the 16S rRNA sequence of Citrobacter gillenii ATCC 51117). | This study |
Klebsiella pneumoniae PMR001 | Isolate from a municipal sewage processing (water purification) plant, Palmerston North, New Zealand (classified by complete 16S rRNA sequencing; 99% identity over 1404 nt to the 16S rRNA sequence of Klebsiella pneumoniae strain ATCC 13883). | This study |
Escherichia coli K12 laboratory strains | ||
 K1508 | MC4100 [F− araD− Δlac U169 relA− thiA rpsL (StrR)] ΔlamB106 | [42] |
 K2403 | K1508 ΔtolC | This study |
 K2424 | K1508 ΔacrA | This study |
 K2425 | K1508 ΔacrA pCA24N::acrA Δgfp | This study |
 K2426 | K1508 ΔtolC pCA24N::tolC Δgfp | This study |
 K2483 | K1508 ΔnfsA ΔnfsB | This study |
 K2505 | K1508 ΔnfsA ΔnfsB ΔahpF | This study |
 K2524 | K1508 pUC118 (AmpR) | This study |